It has been reported that brain metastatic tumor cells could trigger the transformation of astrocyte phenotype through the IL-1β-mediated NF-κB pathway to induce c-Met activation in tumor cells and promote their survival and growth [21]. This evidence concerns the gene NFKB1 and neoplasm.